ClinicalTrials.gov
ClinicalTrials.gov Menu

How Can Rehospitalisations of Patients With Schizophrenia be Avoided? A Comparison Between Different Compliance Programs

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00514423
Recruitment Status : Completed
First Posted : August 10, 2007
Last Update Posted : August 29, 2014
Sponsor:
Information provided by:
Technische Universität München

Brief Summary:
Participation in one of the three interventions psychoeducation by professionals, psychoeducation by peer-moderators, or video-education can reduce the rehospitalisation rate of patients with schizophrenia compared to a control group.

Condition or disease Intervention/treatment Phase
Schizophrenia Schizoaffective Disorder Other: Psychoeducation by professonals Other: Psychoeducation by peer-moderators Other: Video-education Other: Noneducational video group (control group) Not Applicable

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 896 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Prevention
Official Title: How Can Rehospitalisations of Patients With Schizophrenia be Avoided? A Comparison Between Different Compliance Programs
Study Start Date : September 2006
Actual Primary Completion Date : December 2011
Actual Study Completion Date : December 2011

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Schizophrenia

Arm Intervention/treatment
Experimental: 2
Psychoeducation by peer-moderators
Other: Psychoeducation by peer-moderators
Experimental: 1
Psychoeducation by professionals
Other: Psychoeducation by professonals
Experimental: 3
Video-education
Other: Video-education
Placebo Comparator: 4
Control group
Other: Noneducational video group (control group)



Primary Outcome Measures :
  1. Rehospitalisation rate

Secondary Outcome Measures :
  1. Rehospitalisation days
  2. Resulting costs per patient
  3. Compliance
  4. Knowledge of illness
  5. Attitude towards illness
  6. Quality of life
  7. Satisfaction with treatment
  8. Duration of consultation time
  9. Dealing with mental illness


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 67 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Schizophrenia or schizoaffective disorder (ICD-10)
  • Age 18 to 67 years
  • Hospitalised or treated in day care clinic

Exclusion Criteria:

  • More than 12 months of hospitalisation within the last two years
  • Substance-dependency (principal diagnosis)
  • Mental retardation ICD-10 Chapter F70-79
  • Fluency of German language not given

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00514423


Locations
Germany
Klinik und Poliklinik für Psychiatrie und Psychotherapie am Klinikum rechts der Isar der Technischen Universität München
München, Germany, 81675
Sponsors and Collaborators
Technische Universität München
Investigators
Principal Investigator: Werner Kissling, MD Technische Universität München

ClinicalTrials.gov Identifier: NCT00514423     History of Changes
Other Study ID Numbers: 01GL0509
ISRCTN19638644
First Posted: August 10, 2007    Key Record Dates
Last Update Posted: August 29, 2014
Last Verified: August 2014

Additional relevant MeSH terms:
Schizophrenia
Psychotic Disorders
Schizophrenia Spectrum and Other Psychotic Disorders
Mental Disorders